Following publication of our recent article [1] , an error in Figure 5d was noticed. In Figure 5d , the β-actin blot corres ponding to α-SMA blot was captured on the chemi luminescence imaging system in an inverted orientation. Since this imager does not capture the protein marker, an error in the orientation of the membrane while capturing the picture of the blot occurred. During preparation of the fi gures for Figure 5d , the α-SMA blot was in right orientation but since orientation of β-actin blot was inverse as it was captured inversely resulted in non-corresponding β-actin blot with respect to α-SMA blot. We have rectifi ed this error now and β-actin blot now corresponds to α-SMA blot. Th e corrected fi gure 5 is given here as Figure 1 and a supplementary fi gure 1 (Additional fi le 1) showing another set of blots representing Figure 5d is also provided. Representative data from four separate animals per group are shown. *P < 0.05; bleomycin-treated WT and mPGES-1 null mice compared with phosphate-buff ered saline (PBS)-treated mice.
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+ P < 0.05; bleomycin-treated mPGES-1 null mice compared with bleomycin-treated WT mice. (d) Protein extracts from skin tissue after 4 weeks of bleomycin or PBS treatment were subjected to Western blot analysis with an anti-α-SMA antibody. mPGES-1 null mice treated with bleomycin showed reduced α-SMA expression compared with bleomycin-treated WT mice. Representative blot from four separate animals per group is shown. α-SMA, alpha-smooth muscle actin; mPGES-1, microsomal prostaglandin E 2 synthase-1.
